Published • loading... • Updated
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
Investors allege the company overstated its AI partnerships, trading activity and undisclosed ties to a convicted felon, causing losses during the class period.
Summary by The Times and Democrat
9 Articles
9 Articles
AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Class Action
/PRNewswire/ -- Hagens Berman Sobol Shapiro LLP, a national shareholder rights firm, notifies investors in Aardvark Therapeutics, Inc. (NASDAQ: AARD) of a...
·Chicago, United States
Read Full Article
Insulet Deadline: PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit
NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), of the important…
·Indiana, United States
Read Full Article
Coverage Details
Total News Sources9
Leaning Left1Leaning Right1Center6Last UpdatedBias Distribution75% Center
Bias Distribution
- 75% of the sources are Center
75% Center
13%
C 75%
12%
Factuality
To view factuality data please Upgrade to Premium
